Navigation Links
Novavax Reports First Quarter 2008 Financial Results
Date:5/9/2008

ROCKVILLE, Md., May 9 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the first quarter 2008. Novavax reported a net loss of $7.8 million ($0.13 loss per share) for the first quarter of 2008 compared to a net loss of $8.4 million ($0.14 loss per share) for the first quarter of 2007. Total cash and short-term investments as of March 31, 2008 were $40.9 million compared to $46.5 million as of December 31, 2007. The cash burn for the quarter was $5.6 million.

The following are key achievements during the quarter as well as additional plans for the balance of the year:

-- Commenced Phase IIa clinical studies for its H5N1 pandemic influenza

vaccine as a continuation of the original Phase I/IIa trial which

started last year. An interim analysis in December 2007 was favorable,

indicating that this vaccine demonstrated immunogenicity at 15

microgram and 45 microgram dose levels and was well tolerated. The

Company remains on plan to report preliminary immunogenicity results

from the dose-ranging portion of this Phase IIa study in late third

quarter/early fourth quarter of 2008.

-- Continued as planned to advance its seasonal influenza vaccine program

through pre-clinical studies with a target of commencing human trials

in a Phase IIa study in early third quarter of 2008. The Company

believes the initial results from the pandemic influenza vaccine study

bode well for the seasonal program. It is important to note the safety

data generated in the ongoing Phase I/IIa H5N1 pandemic influenza study

will be used to support the safety database for our seasonal program

which will allow us to begin human trials for this program with a Phase

IIa trial.

-- Pending a successful outcome of the Phase IIa trial, an additional

Phase IIb trial of our seasonal infl
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Novavax CEO to Present at BIO CEO & Investor Conference
2. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
3. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Novavax Opens Its First U.S. Vaccine Plant
6. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Contec’s Sporicidin disinfectant solut...grade disinfectants against H1N1 and Influenza A.,...) November 24, 2009 -- Contec Inc, the leading man...that their Sporicidin disinfectants have been de... A viruses, including Pandemic 2009 H1N1 influenza...
(Date:11/23/2009)...ov.23/PRNewswire/-InimexPharmaceuticals,Inc.announ...sPresidentandCEO. ,, Abramsbringsmorethan25year...eisaco-inventorofthenuclearmedicineimagingagent,Ca...lcwherehewasManager,BiomedicalResearchWorldwide.In...CandwasPresidentandCEOfrom1996to2006.AnorMEDdiscov...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,a...ctsforthetreatmentofchronicrespiratorydiseases,tod...sBoardofDirectors.Mr.Rosenhas25yearsofexperiencein...ingkeyrolesatGileadSciencesandALZACorporation.Hisa...ardtosix. ,, "Howiebringsawealthofproductdevelo...
(Date:11/20/2009)..., , , , , , , ,...AUDIO: , A team of scientists from Washington...a, Cold Spring Harbor Laboratory and Iowa State Un...The... , , Click here for more in... , , , , , , , ...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...PRNewswire-FirstCall/ - Lorus Therapeutics Inc. (T..., a biopharmaceutical company,specializing in the ...s and,technologies for the management of cancer, t...evelopment program, including the publication of t...tion and the issuance of a,new patent for Virulizi...
...Xinhua-PRNewswire-FirstCall/ -- China Agritech, In... "the Company"), a leading,liquid organic fertiliz...has entered into a contract with AL-WAHA KHDRAA CO...agricultural and fertilizer products to the Middle... China Agritech over a year ago to,conduct product...
...July 9 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYS...d medical device research,and development outsourc...d,States, today proudly announced that Ms. Trabue ...uXi AppTec,s Atlanta Operations, one of the U.S.,o...Inc., has been invited,to join the Association for...
Other Biology Technology:Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 2Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 3Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 4Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 5Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 6China Agritech to Export Products to Egypt 2China Agritech to Export Products to Egypt 3WuXi AppTec VP and GM Invited to Join the AAMI Standards Board 2WuXi AppTec VP and GM Invited to Join the AAMI Standards Board 3
(Date:11/24/2009)...e is available in Spanish . , The presence ... of inflammatory substances in the blood, hinders ...by a research project of the University of Navarra...t at the School of Pharmacy. , The project, enti...ation to the control of body weight and inflammati...
(Date:11/23/2009)...e, Mass. November 23, 2009 Applied mathematician...Hosta lancifolia ), a characteristic long leaf wit...ripples along the edges. The simple cause of the l...rom bending during differential growthwas revealed...foam ribbons. , Haiyi Liang, a postdoctoral stud...
(Date:11/23/2009)...f. -- More than 160 participants gathered this wee...UTURES INITIATIVE conference. This year,s topic, "...ngineers, and medical researchers to explore the e...ing the emerging field of synthetic biology. , B...t Princeton University and this year,s conference ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 1Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 2Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 3Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 1Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 2Nuvo announces 2009 third quarter financial results 60283 1Nuvo announces 2009 third quarter financial results 60283 2Nuvo announces 2009 third quarter financial results 60283 3Nuvo announces 2009 third quarter financial results 60283 4Nuvo announces 2009 third quarter financial results 60283 5Nuvo announces 2009 third quarter financial results 60283 6Nuvo announces 2009 third quarter financial results 60283 7Nuvo announces 2009 third quarter financial results 60283 8Nuvo announces 2009 third quarter financial results 60283 9Nuvo announces 2009 third quarter financial results 60283 10Nuvo announces 2009 third quarter financial results 60283 11Nuvo announces 2009 third quarter financial results 60283 12
...ith the molecular origins of life and culminating ... the world,s leading experts will report on resear...two-day symposium at Rockefeller University. The s...y, May 2 in the university,s Caspary Auditorium. T...modern science of evolution owes its beginnings to...
...aptivity avoid metals that react with seawater to ...p fishery biologists develop a strategy to reduce ...atch is an increasing priority worldwide given dim...ause sharks compete with target species for baited... operating costs. , A recent study by NOAA scient...
...z is passionate about spiders and the environment.... in the McMicken College of Arts & Sciences, was a...and Applied Ecology at the University of Delaware ... student activist in the anti-war movement as well...dmits. , In the late 1960s, public protests were ...
Other Biology News:Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008 2Can certain metals repel sharks from fishing gear? 2Can certain metals repel sharks from fishing gear? 3UC biology prof traces his roots to the first Earth Day 2UC biology prof traces his roots to the first Earth Day 3
Finnpipette Focus Single Channel Long Tip Cone 30-300l from Thermo Scientific
Hae III (High Concentration) from Takara Mirus Bio
BamH I from New England Biolabs
...ectrophoresis (2D-PAGE) with biological mass spect...atform for proteomic analysis. 2D-PAGE gels offer ...imited only in the dynamic range and ability to re... based analysis of separated proteins has been a m...
Biology Products: